Shares of Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) hit a new 52-week high on Thursday . The company traded as high as $10.68 and last traded at $10.64, with a volume of 190002 shares. The stock had previously closed at $10.43.
Cybin Price Performance
The stock has a market cap of $1.60 billion and a PE ratio of -45.00. The company has a 50-day simple moving average of $10.27 and a 200-day simple moving average of $4.13.
Cybin Company Profile
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Further Reading
- Five stocks we like better than Cybin
- There Are Different Types of Stock To Invest In
- Fast-Growing Companies That Are Still Undervalued
- With Risk Tolerance, One Size Does Not Fit All
- Top Cybersecurity Stock Picks for 2025
- Stock Market Sectors: What Are They and How Many Are There?
- Archer or Joby: Which Aviation Company Might Rise Fastest?
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
